Trial intelligence / Profile preview

Effects of Coenzyme Q10 in PSP and CBD

NCT00532571Phase 3Completed

Sponsor
Lahey Hospital & Medical Center
Start
Jan 2004
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of coenzyme q10 in progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), sponsored by Lahey Hospital & Medical Center. Started Jan 2004; status: completed.

02

Drugs

coenzyme q10
03

Conditions

progressive supranuclear palsy (PSP)corticobasal degeneration (CBD)

Beyond the preview

Go deeper on NCT00532571.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00532571.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call